Remove 2023 Remove Litigation Remove Patent Law
article thumbnail

Fish & Richardson Named a 2023 “Law Firm of the Year” for Intellectual Property Litigation and Patent Litigation by U.S. News – Best Lawyers

Fish & Richardson Trademark & Copyright Thoughts

Fish & Richardson is pleased to announce that the firm has been named a “Law Firm of the Year” for Litigation – Intellectual Property and LitigationPatent in U.S. News & World Report – Best Lawyers “Best Law Firms” 2023 edition. Litigation – Intellectual Property . Patent Law .

article thumbnail

[Hybrid Event] Developments in Pharmaceutical and Biotech Patent Law 2023 - December 1st, New York, NY

JD Supra Law

2023 has seen a fundamental shift in the health care landscape.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Supreme Court on Patent Law: November 2023

Patently-O

by Dennis Crouch The Supreme Court is set to consider several significant patent law petitions addressing a range of issues from the application of obviousness standards, challenges to PTAB procedures, interpretation of joinder time limits IPR, to the proper scope patent eligibility doctrine. Mangrove Partners Master Fund (No.

article thumbnail

Patent Linkage Litigation in China: A Two-Year Review

IP Tech Blog

On June 1, 2021, the Fourth Amendment to the Chinese Patent Law became effective. An important part of the amendment is the introduction by Article 76 of the patent linkage system in China – a system for litigation of drug patents prior to market entry of generics, similar to that provided by the Hatch Waxman Act in the US.

article thumbnail

Court Denies Attempts to Compel Disclosure of Litigation Funding Documents

The IP Law Blog

24, 2023) (Shashi H. Kewalramani), the Central District of California denied Defendant Netflix’s attempts to compel Plaintiff GoTV Streaming to provide documents and further information as to the source of the litigation funding that GoTV received in conjunction with the patent litigation. Netflix, Inc.,

article thumbnail

Keeping up with Belgian patent litigation: Year case law review 2023

The IPKat

Brussels Court of Appeal, 30 January 2023, Biogen v. Mylan In this typical preliminary injunction (PI) case, the Brussels Court of Appeal seems to have refined its case-law. Brussels Court of Appeal, 13 February 2023, Merck Sharp & Dohme v. Is the wind shifting. ? The dispute arose between Biogen and Mylan.

article thumbnail

Restricted Distribution Patent Claims ?Are Not Method-of-Using Claims for the Purpose of ??Listing in ?FDA’s Orange Book

JD Supra Law

In the Hatch-Waxman arena of patent litigation, the crisscross of patent laws and FDA regulations is always in play. Avadel CNS Pharmaceuticals, LLC, 2023 WL 2198640 (Fed. 24, 2023), we see another iteration of this with respect to listing a method-of-use patent in the Orange Book.

Patent 98